Yes, some people do appear to have a natural resistance to chickenpox, though true innate immunity that completely blocks the virus is rare. What’s far more common is that people were exposed to the varicella-zoster virus at some point, developed a mild or entirely symptom-free infection, and built immunity without ever realizing they had chickenpox at all. A smaller number of people may carry a genetic variation that genuinely makes them less susceptible to the virus.
Why Some People Never Get Sick
The most likely explanation for someone who “never got chickenpox” despite repeated exposure is a subclinical infection. The virus entered their body, triggered an immune response, and was controlled so effectively that no rash or fever ever appeared. These people carry antibodies to the virus and are, for all practical purposes, immune. They just never knew they were infected. This is especially common in people exposed during early childhood, when the viral dose from a sibling or classmate may have been low enough for the immune system to handle quietly.
A blood test can settle the question. If your body has immunoglobulin G (IgG) antibodies to varicella-zoster virus at or above 100 mIU/mL, you’re considered immune, regardless of whether you remember being sick. The test can’t tell you whether your antibodies came from a past infection or a vaccination, but either way, they indicate protection.
A Genetic Factor That Reduces Susceptibility
There is at least one known genetic variation that appears to confer real resistance to the virus. A deletion in the CCR5 gene (the same gene involved in HIV resistance) was found to make carriers 9.2 times more likely to test negative for varicella-zoster antibodies compared to people without the deletion. In a study of 157 adult blood donors, 31% of people carrying this deletion were seronegative for the virus, compared to just 4.7% of non-carriers.
This suggests the deletion may interfere with the virus’s ability to establish infection in the first place, or it may alter the immune response in a way that prevents the virus from gaining a foothold. The deletion is most common in people of Northern European descent, where roughly 10% of the population carries at least one copy. It’s not a guarantee of immunity, but it meaningfully shifts the odds.
How Your Immune System Fights the Virus
Even without a special genetic advantage, your body has layered defenses against varicella-zoster virus. The first line is innate immunity: your cells detect the virus through pattern recognition receptors on their surfaces, which recognize the virus’s genetic material and structural proteins. Once detected, cells release signaling proteins called type I interferons that slow viral replication and call in reinforcements like natural killer cells and macrophages.
The second, more powerful line is adaptive immunity. CD4+ T cells coordinate the response and help produce antibodies, while CD8+ T cells directly kill infected cells. After the infection clears, a subset of these cells become memory T cells. Some of them take up permanent residence in your skin, right where the virus would reactivate. These tissue-resident memory T cells express a surface marker called CD69 that anchors them in place, ready to respond within hours if the virus stirs again. Research shows that these skin-based immune cells remain functionally competent even in older adults, though other age-related immune changes can still allow reactivation as shingles.
Natural Infection Produces Stronger Immunity Than Vaccination
If you actually had chickenpox (even without knowing it), your long-term protection is likely stronger than what the vaccine provides. People who recovered from natural infection have significantly higher levels of virus-specific CD4+ T cells and stronger cell-mediated immune responses compared to vaccinated individuals. Antibody levels between the two groups look similar on blood tests, but the deeper T cell response from natural infection appears more robust.
This difference shows up in breakthrough infection rates. Even after two doses of the vaccine, about 2.2% of people develop a mild case of chickenpox over the following decade. Reinfection after natural chickenpox is harder to quantify, though one Japanese study documented that 13% of children presenting with chickenpox had a well-documented previous episode, suggesting clinical recurrence may be more common than once assumed. Still, second cases tend to be milder.
Newborns Get Temporary Protection From Their Mothers
Babies born to mothers who are immune to chickenpox receive antibodies through the placenta. This passive immunity lasts an average of 2.4 months. After that window closes, infants become susceptible. This is why chickenpox in very young babies (under about 3 months) is uncommon but becomes possible once maternal antibodies fade. Babies born to mothers who never had chickenpox or were never vaccinated don’t receive this temporary shield at all.
How to Find Out if You’re Immune
If you’re unsure whether you’ve had chickenpox, the simplest step is a blood test for VZV IgG antibodies. A positive result means you have immunity from a past exposure or vaccination. A negative result means you’re still susceptible. The test can’t distinguish between immunity from natural infection and immunity from vaccination, and a single positive IgG result doesn’t tell you when the exposure happened.
For more specific questions, such as whether an active rash is chickenpox or something else, PCR testing of skin lesions is more sensitive than blood tests. PCR can also distinguish between wild-type virus and the vaccine strain, which matters in rare cases where a vaccinated person develops symptoms.
If your blood test comes back negative and you have no history of chickenpox or vaccination, two doses of the varicella vaccine will give you protection. It won’t be quite as durable as natural infection at the T cell level, but it prevents severe disease effectively and eliminates the risk of complications from a full-blown adult case, which tends to be significantly worse than childhood chickenpox.